Takeda moves ahead in Zika race with launch of vaccine trial

LONDON (Reuters) – Japan’s Takeda Pharmaceutical has moved ahead in the race to develop a vaccine for the mosquito-borne Zika virus, with the start of a clinical trial program backed by the U.S. government.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *